No abstract available
Publication types
-
Clinical Trial, Phase III
-
Editorial
-
Multicenter Study
-
Randomized Controlled Trial
MeSH terms
-
Acute Coronary Syndrome / diagnosis
-
Acute Coronary Syndrome / drug therapy*
-
Acute Coronary Syndrome / mortality*
-
Clopidogrel
-
Dose-Response Relationship, Drug
-
Double-Blind Method
-
Drug Administration Schedule
-
Female
-
Humans
-
Incidence
-
Male
-
Myocardial Infarction / diagnosis*
-
Myocardial Infarction / drug therapy
-
Myocardial Infarction / mortality*
-
Piperazines / administration & dosage*
-
Piperazines / adverse effects
-
Piperazines / pharmacology
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / adverse effects
-
Prasugrel Hydrochloride
-
Prognosis
-
Risk Assessment
-
Survival Analysis
-
Thiophenes / administration & dosage*
-
Thiophenes / adverse effects
-
Thiophenes / pharmacology
-
Ticlopidine / administration & dosage
-
Ticlopidine / adverse effects
-
Ticlopidine / analogs & derivatives
-
Treatment Outcome
-
United States
-
United States Food and Drug Administration
Substances
-
Piperazines
-
Platelet Aggregation Inhibitors
-
Thiophenes
-
Clopidogrel
-
Prasugrel Hydrochloride
-
Ticlopidine